A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma
The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations.
Inclusion Criteria:
Exclusion Criteria:
CABA, Buenos Aires C1426ABP, Argentina
Ciudad Autonoma de Buenos Aires, Buenos Aires C1128AAF, Argentina
Mar del Plata, Buenos Aires 7600, Argentina
San Juan Bautista, Buenos Aires 1888, Argentina
Buenos Aires, Distrito Federal 1425, Argentina
Rosario, Santa Fe Province S2002OJN, Argentina
Florida, Vicente Lopez, B1602DQD, Argentina
Rousse, 7002, Bulgaria
Bogota, Cundinamarca 11001, Colombia
Bogota, Cundinamarca 110221, Colombia
Shatin, New Territories, Hong Kong
Yoshida-gun, Fukui 910-1193, Japan
Mizunami-shi, Gifu 509-6134, Japan
Sakaide-shi, Kagawa-ken 762-8550, Japan
Nankoku-shi, Kochi 783-8505, Japan
Toyonaka-shi, Osaka 560-8552, Japan
Itabashi-ku, Tokyo 173-8606, Japan
Shinagawa-ku, Tokyo 140-8522, Japan
Guadalaja, Jalisco 44160, Mexico
Ostrowiec Świętokrzyski, 27-400, Poland
Craiova, 200515, Romania